GHK-Cu and photoageing: what the UV-damage literature actually examines

GHK is three amino acids — glycine, histidine, lysine — holding a copper(II) ion. It was isolated from human plasma in the early 1970s, and the first decade of work on it was about tissue repair. Photoageing is a later and separate thread, and it is the one most people arrive by.

It is worth separating from the rest of the skin literature for a reason that has nothing to do with marketing: photoaged skin is not old skin. The two have different biology, different markers and different experimental designs, and a finding in one does not carry across. What follows is what the published photoageing work examines, who did it, and where it runs out. For the repair literature it grew from, see GHK-Cu for Wound Healing Research. Nothing here is medical, dosing, or therapeutic guidance.

Photoageing is not chronological ageing

The practical consequence is that photoageing research uses endpoints intrinsic-ageing research does not: UV-induced MMP expression, elastotic change, markers of fragmented dermal collagen. A compound examined only against collagen synthesis in a dish has been examined against one half of one of those.

Why the peptide turns up in this literature at all

Three properties account for the interest, and they are related rather than independent.

Matrix degradation. Photoageing is, mechanistically, a degradation problem before it is a synthesis problem. UV exposure raises MMP activity — MMP-1 in particular — and those enzymes cut collagen and elastin faster than fibroblasts replace them. Published GHK-Cu work has examined MMP expression and its balance against the tissue inhibitors of metalloproteinases, which is the same axis photoageing runs on (PMID 29986520).

Collagen synthesis. The other half of the same imbalance. The reported effect on fibroblast collagen production is the oldest and most-replicated GHK finding, and it is the subject of the compound's tissue-remodelling literature (PMID 18644225).

Breadth of gene expression. The figure quoted everywhere — that GHK affects the expression of a large number of human genes, including genes in antioxidant defence, DNA repair and matrix remodelling — comes from Pickart's group's analysis of an existing public gene-expression dataset rather than from experiments in photoaged skin (PMID 26236730). That is a real result and a weak one for this purpose: a transcript signature in a database is several steps away from a change in a dermis.

Copper itself is doing work in all three. Superoxide dismutase and lysyl oxidase are copper-dependent enzymes, the first in oxidative defence and the second in collagen crosslinking, and both are relevant to UV-damaged skin. But that is a fact about copper biology, not a demonstration that this peptide feeds those enzymes in skin. The distinction gets elided constantly in writing about copper peptides, and it should not be.

What the photoageing references are actually about

Two of the standard references in this area — Fisher and colleagues on collagen fragmentation and MMP-1 in aged human skin, and Quan and Fisher on the dermal matrix microenvironment — contain no GHK-Cu at all. They establish the photoageing framework the peptide is discussed against. That is a legitimate use of a citation and it is not evidence about the compound, and a reference list that mixes the two without saying so reads stronger than it is.

The GHK-specific papers are largely reviews, and largely Pickart's. Loren Pickart identified the tripeptide and has published on it for decades; the two most-cited modern sources here (PMID 29986520, PMID 26236730) are syntheses from that group rather than new experiments. One author's reviews being the principal account of a compound is the single most useful thing to know before reading any of it.

Where the evidence stops

Culture and formulation, mostly. The mechanistic work is in fibroblast and skin-cell culture. The human-facing photoageing evidence is cosmetic-formulation work: a finished cream at a low concentration in a vehicle designed to carry copper through the stratum corneum, measured on appearance endpoints such as fine-line parameters and skin roughness.

That evidence does not transfer to this material. This is the honest and uncomfortable part. A cosmetic trial tests a formulation. The research-use compound sold here is a lyophilised powder with no vehicle, no penetration enhancer and no stability work behind any particular diluent. Whatever a cream study reported, it reported about the cream.

No controlled trial exists for the research-use form. None for photoageing, none for anything else.

It is not an approved drug. Not by Health Canada, not by the FDA, not by the EMA, for any indication. Copper tripeptide-1 appears in cosmetic ingredient listings, which is a safety-and-labelling regime — it says a substance may be put in a product, not that it does anything. Reading a cosmetic listing as an efficacy finding is the most common error in this field.

Reported mechanism is not reported appearance. A shift in MMP expression in culture is a measurement about enzymes. Whether it produces a visible change in photoaged human skin is a different question, asked with different instruments, and it has not been settled for this compound.

Designing a question around it

Photoageing is slow. Useful designs run weeks to months, not days, which is the main structural difference from the wound work. The endpoints that engage the actual biology are MMP-1, MMP-3 and MMP-9 expression, elastin and collagen fragmentation markers, and — if appearance is in scope at all — instrumented roughness or line measurement rather than photographs. For the parallel anti-inflammatory and multi-component threads, the KLOW Blend breakdown covers how this peptide is combined with others (Inside the KLOW Blend).

Reconstitution is arithmetic, not guidance: a 50 mg vial taken up in 5 mL of diluent gives 10 mg/mL, and the 100 mg vial in the same volume gives 20 mg/mL. What a protocol does with that is the protocol's business.

GHK-Cu is supplied here as GHK-Cu, in 50 mg and 100 mg vials. Janoshik-verified by HPLC with mass-spec identity confirmation; 100% synthetic. The measured purity for each lot is stated on its product page. For laboratory research use only.

Common questions

Is GHK-Cu proven to reverse sun damage? No. Published work examines MMP expression, collagen synthesis and gene-expression signatures, mostly in culture, plus cosmetic-formulation studies on appearance measures. No controlled trial has established an effect on photoaged skin for the material sold here, and no regulator has approved it for anything.

Does the copper matter, or is it the peptide? The copper complex and the metal-free tripeptide are reported to behave differently, which is why the field is 'copper peptides' rather than 'peptides'. What has not been shown is that supplying copper this way changes the activity of the copper-dependent enzymes people invoke when explaining it.

Why is so much of the literature by one author? Pickart identified GHK and built the field around it. The concentration is historical rather than suspicious, but it means most of the framing, and most of the mechanism-stacking, shares one set of assumptions. Independent replication is what to look for when reading.

How does this differ from the wound-repair literature? Shared mechanisms, different endpoints and timescales. Wound work measures closure, fibroblast behaviour and matrix deposition over days to weeks; photoageing work measures degradation markers and appearance over months. See GHK-Cu for Wound Healing Research.

Selected Research References

1. Pickart L, Margolina A. Regenerative and Protective Actions of the GHK-Cu Peptide. International Journal of Molecular Sciences. 2018;19(7):1987. pubmed.ncbi.nlm.nih.gov/29986520
2. Pickart L, Vasquez-Soltero JM, Margolina A. GHK Peptide as a Natural Modulator of Multiple Cellular Pathways in Skin Regeneration. BioMed Research International. 2015;2015:648108. pubmed.ncbi.nlm.nih.gov/26236730
3. Fisher GJ, Quan T, Purohit T, et al. Collagen Fragmentation Promotes Oxidative Stress and Elevates Matrix Metalloproteinase-1 in Fibroblasts in Aged Human Skin. American Journal of Pathology. 2009;174(1):101-114. (Reference on photoaging MMP biology framework.)
4. Pickart L. The Human Tri-Peptide GHK and Tissue Remodeling. Journal of Biomaterials Science, Polymer Edition. 2008;19(8):969-988. pubmed.ncbi.nlm.nih.gov/18644225
5. Quan T, Fisher GJ. Role of Age-Associated Alterations of the Dermal Extracellular Matrix Microenvironment in Human Skin Aging: A Mini-Review. Gerontology. 2015;61(5):427-434. (Reference on dermal matrix biology in skin aging.)

All products sold by NovaEvum are for research and laboratory use only. They are not intended for human or animal consumption, diagnosis, treatment, cure, or prevention of any disease.